|Articles|July 31, 1998

August 1998
Volume 4
Issue 8

The Clinical Value of Commonly Used Spinal Fluid Diagnostic Studies in the Evaluation of Patients with Suspected Multiple Sclerosis

Author(s)George W. Brasher, MD, Alan B. Follender, MD, A. Michael Spiekerman, PhD

Download PDF: The Clinical Value of Commonly Used Spinal Fluid Diagnostic Studies in the Evaluation of Patients with Suspected Multiple Sclerosis

Articles in this issue

about 28 years ago

Article

The Impact of Reimbursement Changes for Intracoronary Stents on Providers and Medicare

about 28 years ago

Article

Formulary Limitations and the Elderly: Results from the Managed Care Outcomes Project

about 28 years ago

Article

The Cost of Inpatient Endometriosis Treatment: An Analysis Based on the Healthcare Cost and Utilization Project Nationwide Inpatient Sample

about 28 years ago

Article

Identification and Assessment of High-Risk Seniors

about 28 years ago

Article

Outpatient Antidepressant Utilization in a Dutch Sick Fund

about 28 years ago

Article

Inborn Errors of Metabolism: Medical and Administrative "Orphans"

about 28 years ago

Article

Treatment Options for Prostate Cancer: Part 2 -- Early and Late Stage and Hormone Refractory Disease

about 28 years ago

Article

Generic Drug Product Equivalence: Current Status

about 28 years ago

Article

Correspondence regarding, "A Cost-Effectiveness Clinical Decision Analysis Model for Schizophrenia"

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

The Clinical Value of Commonly Used Spinal Fluid Diagnostic Studies in the Evaluation of Patients with Suspected Multiple Sclerosis

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Panel Backs 6 Peptides for Compounding

Oncology Leaders Call for Greater Collaboration to Advance Precision Medicine, Innovative Cancer Care

Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%

Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access

FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies